| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | late endosome lumen | 2.59e-07 | 11 | 113 | 4 | GO:0031906 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 5.30e-06 | 7 | 113 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | endosome lumen | 8.49e-05 | 43 | 113 | 4 | GO:0031904 | |
| Domain | Aspartic_peptidase_N | 7.42e-06 | 7 | 113 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 7.42e-06 | 7 | 113 | 3 | PF07966 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.18e-05 | 8 | 113 | 3 | IPR019565 | |
| Domain | Thiol-ester_cl | 1.18e-05 | 8 | 113 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.18e-05 | 8 | 113 | 3 | IPR019742 | |
| Domain | A2M_N_2 | 1.18e-05 | 8 | 113 | 3 | SM01359 | |
| Domain | - | 1.18e-05 | 8 | 113 | 3 | 2.60.40.690 | |
| Domain | A2M_recep | 1.18e-05 | 8 | 113 | 3 | SM01361 | |
| Domain | A2M | 1.18e-05 | 8 | 113 | 3 | SM01360 | |
| Domain | BEACH | 1.76e-05 | 9 | 113 | 3 | PS50197 | |
| Domain | Beach | 1.76e-05 | 9 | 113 | 3 | PF02138 | |
| Domain | - | 1.76e-05 | 9 | 113 | 3 | 1.10.1540.10 | |
| Domain | Beach | 1.76e-05 | 9 | 113 | 3 | SM01026 | |
| Domain | BEACH_dom | 1.76e-05 | 9 | 113 | 3 | IPR000409 | |
| Domain | Aspartic_peptidase_A1 | 2.51e-05 | 10 | 113 | 3 | IPR001461 | |
| Domain | A2M | 2.51e-05 | 10 | 113 | 3 | PF00207 | |
| Domain | A2M_N_2 | 2.51e-05 | 10 | 113 | 3 | IPR011625 | |
| Domain | A2M_comp | 2.51e-05 | 10 | 113 | 3 | IPR011626 | |
| Domain | A2M_recep | 2.51e-05 | 10 | 113 | 3 | PF07677 | |
| Domain | A2M_comp | 2.51e-05 | 10 | 113 | 3 | PF07678 | |
| Domain | A2M_N | 2.51e-05 | 10 | 113 | 3 | PF01835 | |
| Domain | A2M_N | 2.51e-05 | 10 | 113 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.51e-05 | 10 | 113 | 3 | IPR009048 | |
| Domain | PEPTIDASE_A1 | 2.51e-05 | 10 | 113 | 3 | IPR033121 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.51e-05 | 10 | 113 | 3 | PS00477 | |
| Domain | A2M_N_2 | 2.51e-05 | 10 | 113 | 3 | PF07703 | |
| Domain | Asp | 2.51e-05 | 10 | 113 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 2.51e-05 | 10 | 113 | 3 | PS51767 | |
| Domain | Macroglobln_a2 | 2.51e-05 | 10 | 113 | 3 | IPR001599 | |
| Domain | - | 4.56e-05 | 12 | 113 | 3 | 2.40.70.10 | |
| Domain | - | 4.56e-05 | 12 | 113 | 3 | 1.50.10.20 | |
| Domain | ASP_PROTEASE | 4.56e-05 | 12 | 113 | 3 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 5.90e-05 | 13 | 113 | 3 | IPR001969 | |
| Domain | Bromodomain | 8.00e-05 | 38 | 113 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.08e-04 | 41 | 113 | 4 | PS50014 | |
| Domain | Bromodomain | 1.19e-04 | 42 | 113 | 4 | IPR001487 | |
| Domain | BROMO | 1.19e-04 | 42 | 113 | 4 | SM00297 | |
| Domain | - | 1.19e-04 | 42 | 113 | 4 | 1.20.920.10 | |
| Domain | Peptidase_aspartic_dom | 1.38e-04 | 17 | 113 | 3 | IPR021109 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.65e-04 | 18 | 113 | 3 | IPR008930 | |
| Domain | EFG_IV | 2.16e-04 | 4 | 113 | 2 | SM00889 | |
| Domain | EFG_IV | 2.16e-04 | 4 | 113 | 2 | PF03764 | |
| Domain | Transl_elong_EFG/EF2_IV | 2.16e-04 | 4 | 113 | 2 | IPR005517 | |
| Domain | EFG_II | 3.59e-04 | 5 | 113 | 2 | PF14492 | |
| Domain | VWA | 3.66e-04 | 56 | 113 | 4 | PF00092 | |
| Domain | Bromodomain_CS | 5.07e-04 | 26 | 113 | 3 | IPR018359 | |
| Domain | EFG_C | 5.36e-04 | 6 | 113 | 2 | PF00679 | |
| Domain | PH_BEACH | 5.36e-04 | 6 | 113 | 2 | PF14844 | |
| Domain | EFG_III-V | 5.36e-04 | 6 | 113 | 2 | IPR009022 | |
| Domain | EFG_C | 5.36e-04 | 6 | 113 | 2 | SM00838 | |
| Domain | - | 7.47e-04 | 7 | 113 | 2 | 3.30.70.240 | |
| Domain | EFG_V | 7.47e-04 | 7 | 113 | 2 | IPR000640 | |
| Domain | Acyl-CoA-binding_protein | 9.92e-04 | 8 | 113 | 2 | IPR000582 | |
| Domain | PH-BEACH_dom | 9.92e-04 | 8 | 113 | 2 | IPR023362 | |
| Domain | - | 9.92e-04 | 8 | 113 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 9.92e-04 | 8 | 113 | 2 | PS51783 | |
| Domain | ARM-type_fold | 1.06e-03 | 339 | 113 | 8 | IPR016024 | |
| Domain | BROMODOMAIN_1 | 1.44e-03 | 37 | 113 | 3 | PS00633 | |
| Domain | VWFA | 1.55e-03 | 82 | 113 | 4 | PS50234 | |
| Domain | VWA | 1.69e-03 | 84 | 113 | 4 | SM00327 | |
| Domain | G_TR_1 | 2.71e-03 | 13 | 113 | 2 | PS00301 | |
| Domain | HEAT | 3.06e-03 | 48 | 113 | 3 | PF02985 | |
| Domain | VWF_A | 3.08e-03 | 99 | 113 | 4 | IPR002035 | |
| Domain | C2_dom | 3.22e-03 | 164 | 113 | 5 | IPR000008 | |
| Domain | - | 3.24e-03 | 49 | 113 | 3 | 1.20.80.10 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 3.44e-03 | 50 | 113 | 3 | IPR014352 | |
| Domain | EF-hand_like | 3.62e-03 | 15 | 113 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 3.62e-03 | 15 | 113 | 2 | PF00387 | |
| Domain | PLCYc | 3.62e-03 | 15 | 113 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 3.62e-03 | 15 | 113 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 3.62e-03 | 15 | 113 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 3.62e-03 | 15 | 113 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 3.62e-03 | 15 | 113 | 2 | IPR015359 | |
| Domain | PH_dom-like | 4.37e-03 | 426 | 113 | 8 | IPR011993 | |
| Domain | WD40 | 4.93e-03 | 259 | 113 | 6 | PF00400 | |
| Domain | EFTu-like_2 | 5.21e-03 | 18 | 113 | 2 | IPR004161 | |
| Domain | PI-PLC-X | 5.21e-03 | 18 | 113 | 2 | PF00388 | |
| Domain | PLCXc | 5.21e-03 | 18 | 113 | 2 | SM00148 | |
| Domain | GTP_EFTU_D2 | 5.21e-03 | 18 | 113 | 2 | PF03144 | |
| Domain | G_TR_2 | 5.21e-03 | 18 | 113 | 2 | PS51722 | |
| Domain | HEAT | 5.23e-03 | 58 | 113 | 3 | IPR000357 | |
| Domain | Kinase-like_dom | 5.65e-03 | 542 | 113 | 9 | IPR011009 | |
| Domain | TF_GTP-bd_dom | 5.80e-03 | 19 | 113 | 2 | IPR000795 | |
| Domain | PIPLC_X_DOMAIN | 5.80e-03 | 19 | 113 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 5.80e-03 | 19 | 113 | 2 | IPR000909 | |
| Domain | WD40 | 5.81e-03 | 268 | 113 | 6 | SM00320 | |
| Domain | ARM-like | 6.02e-03 | 270 | 113 | 6 | IPR011989 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 3.61e-05 | 11 | 87 | 3 | M39726 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 7926498 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 9561228 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 21455714 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 19800305 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 3.43e-08 | 3 | 114 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 3.43e-08 | 3 | 114 | 3 | 2799289 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 3.43e-08 | 3 | 114 | 3 | 1968039 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 8053437 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 3.43e-08 | 3 | 114 | 3 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 3.43e-08 | 3 | 114 | 3 | 2229438 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 3.43e-08 | 3 | 114 | 3 | 19890696 | |
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 3.43e-08 | 3 | 114 | 3 | 8244094 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 21407214 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 6774973 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 3.43e-08 | 3 | 114 | 3 | 22304859 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 24004680 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 3.43e-08 | 3 | 114 | 3 | 2227273 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 23034090 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 24125879 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 3.43e-08 | 3 | 114 | 3 | 3554488 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 23521833 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 3.43e-08 | 3 | 114 | 3 | 21989121 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 9855083 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 9797498 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 2478370 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 3.43e-08 | 3 | 114 | 3 | 10675278 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 3780036 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 3.43e-08 | 3 | 114 | 3 | 3839486 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 3467902 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 3.43e-08 | 3 | 114 | 3 | 2892778 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 24383519 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 3.43e-08 | 3 | 114 | 3 | 2831884 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 2032552 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 1812762 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 7923573 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 3.43e-08 | 3 | 114 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 3.43e-08 | 3 | 114 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 3.43e-08 | 3 | 114 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 3.43e-08 | 3 | 114 | 3 | 1956484 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 8540382 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 3.43e-08 | 3 | 114 | 3 | 20981206 | |
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 3.43e-08 | 3 | 114 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 3.43e-08 | 3 | 114 | 3 | 21970995 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 20428942 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 9525001 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 7886402 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 17379991 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 21547904 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 RIN3 VWA8 MYO10 MED14 ARFGEF2 RAPGEF1 MAPKAPK5 LYST TIAM2 CDK5R1 FAT1 C2CD3 PLCG1 LTK LRBA SYMPK | 1.24e-07 | 1105 | 114 | 17 | 35748872 |
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 1.37e-07 | 4 | 114 | 3 | 23047493 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 1.37e-07 | 4 | 114 | 3 | 11915945 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 8322031 | ||
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 1.37e-07 | 4 | 114 | 3 | 17136346 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 12698190 | ||
| Pubmed | 3.23e-07 | 18 | 114 | 4 | 36057966 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 22066020 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | FLT1 ENPP2 SMCHD1 LYST INTS6 FAT1 DPH5 CLCA2 PRCP A2ML1 TAF1 | 2.15e-06 | 552 | 114 | 11 | 10737800 |
| Pubmed | VWA8 ZMYND8 YY1 INTS10 SNIP1 SETDB1 INTS6 FAT1 PTPN14 PBRM1 BRDT CBY2 TAF1 LTK ILVBL | 3.85e-06 | 1116 | 114 | 15 | 31753913 | |
| Pubmed | Multiple roles of epithelial heparan sulfate in stomach morphogenesis. | 5.30e-06 | 35 | 114 | 4 | 29700203 | |
| Pubmed | Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. | 1.01e-05 | 41 | 114 | 4 | 23676500 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 11352564 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 2714789 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 3197840 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24494199 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24360193 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 21840483 | ||
| Pubmed | Direct binding of p130(Cas) to the guanine nucleotide exchange factor C3G. | 1.07e-05 | 2 | 114 | 2 | 9748234 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9299537 | ||
| Pubmed | Crystal structure of human pepsin and its complex with pepstatin. | 1.07e-05 | 2 | 114 | 2 | 7663352 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 20231358 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 2415509 | ||
| Pubmed | Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers. | 1.07e-05 | 2 | 114 | 2 | 11312102 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 32334006 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.45e-05 | 332 | 114 | 8 | 32786267 | |
| Pubmed | 2.70e-05 | 18 | 114 | 3 | 24025402 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.74e-05 | 363 | 114 | 8 | 14691545 | |
| Pubmed | IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling. | 3.19e-05 | 3 | 114 | 2 | 22279049 | |
| Pubmed | PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells. | 3.19e-05 | 3 | 114 | 2 | 32294598 | |
| Pubmed | Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritis. | 3.19e-05 | 3 | 114 | 2 | 19296842 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 32704025 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 28557373 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 25856795 | ||
| Pubmed | Identification of risk loci for Crohn's disease phenotypes using a genome-wide association study. | 3.19e-05 | 3 | 114 | 2 | 25557950 | |
| Pubmed | Myosin 10 Regulates Invasion, Mitosis, and Metabolic Signaling in Glioblastoma. | 3.19e-05 | 3 | 114 | 2 | 33299973 | |
| Pubmed | alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis. | 3.19e-05 | 3 | 114 | 2 | 10487856 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 9927060 | ||
| Pubmed | PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma. | 3.19e-05 | 3 | 114 | 2 | 19483472 | |
| Interaction | UCN3 interactions | 7.64e-06 | 23 | 113 | 4 | int:UCN3 | |
| Cytoband | 10q23.3 | 1.27e-04 | 7 | 114 | 2 | 10q23.3 | |
| Cytoband | 3q22.1 | 1.60e-04 | 42 | 114 | 3 | 3q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q22 | 3.71e-04 | 135 | 114 | 4 | chr3q22 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.79e-06 | 9 | 71 | 3 | 1234 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 4.79e-06 | 9 | 71 | 3 | 1230 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 5.17e-04 | 40 | 71 | 3 | 321 | |
| GeneFamily | WD repeat domain containing | 5.70e-04 | 262 | 71 | 6 | 362 | |
| GeneFamily | Integrator complex | 1.54e-03 | 15 | 71 | 2 | 1366 | |
| GeneFamily | Cadherin related | 1.99e-03 | 17 | 71 | 2 | 24 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 2.49e-03 | 19 | 71 | 2 | 832 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYO10 SMCHD1 MARCHF6 ZMYND8 TOPBP1 SOCS6 PTEN YY1 RYK PIK3R4 SETDB1 FAT1 C2CD3 PHLPP1 | 1.94e-05 | 856 | 113 | 14 | M4500 |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_UP | 2.02e-05 | 437 | 113 | 10 | M15981 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP | 2.64e-05 | 200 | 113 | 7 | M8042 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NKTCELL_UP | 2.64e-05 | 200 | 113 | 7 | M4839 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP | 2.64e-05 | 200 | 113 | 7 | M9208 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | FAT4 ABCA1 SGMS2 IQGAP2 ENPP2 CD109 MED14 ARFGEF2 PTEN TIAM2 CDK5R1 C2CD3 CSRNP3 FRZB TNKS2 LY75 | 2.79e-06 | 769 | 112 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | FAT4 ABCA1 IQGAP2 MYO10 MED14 ARFGEF2 SOCS6 RUFY2 SETDB1 CDK5R1 C2CD3 CLCA2 CSRNP3 FRZB PDE5A TNKS2 | 5.06e-06 | 806 | 112 | 16 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.02e-05 | 261 | 112 | 9 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 1.42e-05 | 149 | 112 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.53e-05 | 209 | 112 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | ABCA1 IQGAP2 MYO10 MED14 ARFGEF2 SOCS6 RUFY2 SETDB1 C2CD3 TNKS2 | 2.61e-05 | 369 | 112 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | FAT4 ABCA1 IQGAP2 MYO10 ARFGEF2 CDK5R1 C2CD3 CLCA2 PDE5A TNKS2 | 5.96e-05 | 407 | 112 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | FAT4 ABCA1 IQGAP2 ARFGEF2 SETDB1 CLCA2 CSRNP3 FRZB PDE5A TNKS2 | 6.09e-05 | 408 | 112 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | ABCA1 AHI1 MYO10 MARCHF6 MED14 WDR81 CEMIP2 FAT1 C2CD3 CSRNP3 PHLPP1 DHX32 TTLL1 ELK4 MGAT5B | 7.06e-05 | 893 | 112 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | FAT4 ABCA1 AHI1 IQGAP2 VWA8 MYO10 ARFGEF2 SETDB1 CDK5R1 C2CD3 CLCA2 FRZB PDE5A TNKS2 | 8.81e-05 | 806 | 112 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 9.60e-05 | 201 | 112 | 7 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | FAT4 ABCA1 SGMS2 AHI1 IQGAP2 ARFGEF2 SOCS6 PTEN RYR2 RUFY2 SETDB1 CLCA2 CSRNP3 TNKS2 | 1.03e-04 | 818 | 112 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 1.22e-04 | 209 | 112 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.25e-04 | 146 | 112 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.69e-04 | 375 | 112 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_200 | 2.04e-04 | 22 | 112 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 2.28e-04 | 163 | 112 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | AHI1 PUS3 MYO10 TOM1L1 MED14 ARFGEF2 RYK INTS10 CDK5R1 C2CD3 FRZB TNKS2 LY75 | 2.36e-04 | 779 | 112 | 13 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.52e-04 | 312 | 112 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | 2.82e-04 | 402 | 112 | 9 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | AHI1 IQGAP2 VWA8 MYO10 ENPP2 MED14 ARFGEF2 RYK SGK2 RUFY2 C2CD3 PTPN14 TNKS2 | 2.88e-04 | 795 | 112 | 13 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 3.45e-04 | 327 | 112 | 8 | GSM538380_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.66e-04 | 330 | 112 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_200 | 3.76e-04 | 116 | 112 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_200 | 3.77e-04 | 179 | 112 | 6 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | FAT4 ABCA1 AHI1 IQGAP2 MYO10 MED14 RYR2 CDK5R1 C2CD3 CLCA2 FRZB PDE5A TNKS2 | 3.78e-04 | 818 | 112 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.38e-04 | 339 | 112 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.38e-04 | 339 | 112 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.76e-04 | 187 | 112 | 6 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#3_top-relative-expression-ranked_500 | 6.35e-04 | 74 | 112 | 4 | gudmap_developingKidney_e15.5_S-shaped body_500_k3 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.41e-07 | 187 | 114 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-07 | 194 | 114 | 7 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.17e-07 | 195 | 114 | 7 | 81a98ebb0d43f416f9a8bba580531dc0cfea8f74 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.50e-07 | 200 | 114 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.50e-07 | 200 | 114 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.50e-07 | 200 | 114 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-06 | 178 | 114 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.03e-06 | 180 | 114 | 6 | 81d60f0fa9e3b5bfcec85139a0a49e9130145f0e | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.22e-06 | 185 | 114 | 6 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.48e-06 | 186 | 114 | 6 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-06 | 186 | 114 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.74e-06 | 187 | 114 | 6 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.74e-06 | 187 | 114 | 6 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 9.57e-06 | 190 | 114 | 6 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.57e-06 | 190 | 114 | 6 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.57e-06 | 190 | 114 | 6 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.86e-06 | 191 | 114 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 192 | 114 | 6 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 193 | 114 | 6 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 193 | 114 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 193 | 114 | 6 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-05 | 194 | 114 | 6 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 195 | 114 | 6 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 195 | 114 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-05 | 196 | 114 | 6 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 197 | 114 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 197 | 114 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 197 | 114 | 6 | 0542badae77d2f606c13cfaf361319495c354351 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 197 | 114 | 6 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 197 | 114 | 6 | a6a64581699cfcb9607b288976fa3b09648725b7 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.21e-05 | 198 | 114 | 6 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-05 | 199 | 114 | 6 | 68412bc39639edc4045437d62548f7101b9f1989 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.25e-05 | 199 | 114 | 6 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-05 | 199 | 114 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 199 | 114 | 6 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | medial-Endothelial-Vein-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.28e-05 | 200 | 114 | 6 | 3f689029f5bc7db0af50a405f1e252aeec529077 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | medial-Endothelial-Vein|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.28e-05 | 200 | 114 | 6 | 1163e5f6dfb304c94bf8885629350454f4b6bee8 | |
| ToppCell | medial-2-Endothelial-Vein|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.28e-05 | 200 | 114 | 6 | 49da4e3ff10262a492c2cf566a7f2e35e418bfda | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.55e-05 | 135 | 114 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | NS-critical-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.47e-05 | 144 | 114 | 5 | 0fde5cd82df9b90aefde19275cff6c2ec3c9d5cb | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 5.09e-05 | 156 | 114 | 5 | 19472ef1642c2ad333aa3ce3675a25c6ab1d4556 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.09e-05 | 156 | 114 | 5 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-05 | 160 | 114 | 5 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-05 | 160 | 114 | 5 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | 4cdd80580d5638fd649280ba3893251c2f898f3f | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 166 | 114 | 5 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.23e-05 | 168 | 114 | 5 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.23e-05 | 168 | 114 | 5 | 83b4f817d95daa15ae60668e789f97d8a3b2e6dd | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 169 | 114 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 7.64e-05 | 170 | 114 | 5 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 174 | 114 | 5 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | severe_influenza-pDC|severe_influenza / disease group, cell group and cell class (v2) | 8.53e-05 | 174 | 114 | 5 | d8d2ded5812ed3b3db4109585714a6513c13326a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 174 | 114 | 5 | 95464817adef5ad2038bbf542f315756b7ad862e | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.76e-05 | 175 | 114 | 5 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.00e-05 | 176 | 114 | 5 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | CF-Lymphoid-pDC|CF / Disease state, Lineage and Cell class | 9.00e-05 | 176 | 114 | 5 | dd1e529a9e413bcaab43584afbe059e1464ffb53 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-05 | 177 | 114 | 5 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-05 | 177 | 114 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-05 | 177 | 114 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|myeloid / Lineage, cell class and subclass | 9.49e-05 | 178 | 114 | 5 | f75591988bbbeba073b66329a3437cb9b02f7648 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.49e-05 | 178 | 114 | 5 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-05 | 178 | 114 | 5 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-05 | 179 | 114 | 5 | b70509288aaf4457afd350f6c45784521337ce0d | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 181 | 114 | 5 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 181 | 114 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 181 | 114 | 5 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 182 | 114 | 5 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 182 | 114 | 5 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 183 | 114 | 5 | 28e1fc6498aaf8f42c4d6d4fa54ffff4c546d0d1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-04 | 183 | 114 | 5 | 3b123571e10c132227aff65648b4b3c6acb4bd00 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-04 | 183 | 114 | 5 | df6fd0927b6e4cf9a1583969a68096e4bccfbace | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 183 | 114 | 5 | 667d9107af17fd076ceff6b2cbcb78f892fd62d2 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.11e-04 | 184 | 114 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-04 | 184 | 114 | 5 | a902109b04a94770f5f6db5ddc372049f2921d38 | |
| ToppCell | (7)_MNP-(7)_DC_plasmacytoid|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.14e-04 | 185 | 114 | 5 | 9f67f652488e17075a372e2a2e1100f6d0af6d7d | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 1.14e-04 | 185 | 114 | 5 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 185 | 114 | 5 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 185 | 114 | 5 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 185 | 114 | 5 | 68edb1bb03ed221d49e583123ca4de14252d7bc5 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 186 | 114 | 5 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-04 | 186 | 114 | 5 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 186 | 114 | 5 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 187 | 114 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.20e-04 | 187 | 114 | 5 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 187 | 114 | 5 | d6765854154557794815514c0aa355bc74b8523e | |
| ToppCell | COVID-19_Severe-pDC-|COVID-19_Severe / Disease condition and Cell class | 1.23e-04 | 188 | 114 | 5 | 9fd1116e31a05554850b8ed3c005ea660dfbd51c | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 188 | 114 | 5 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 188 | 114 | 5 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.23e-04 | 188 | 114 | 5 | bcfc426b60d8e5a23a2360bfb68b32868fec9fbf | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 188 | 114 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | COVID-19_Mild-pDC|COVID-19_Mild / Disease condition and Cell class | 1.23e-04 | 188 | 114 | 5 | 62d33d2990d4a2d32bd0863147e47f656df1966e | |
| ToppCell | COVID-19_Mild-pDC-|COVID-19_Mild / Disease condition and Cell class | 1.23e-04 | 188 | 114 | 5 | a75c2cf2f8dae343c13aaa66b637658b935ed10a | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / Disease condition and Cell class | 1.23e-04 | 188 | 114 | 5 | 475008f45673b42b75ef231c2df91f8b9adc9201 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 189 | 114 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 6.42e-08 | 199 | 114 | 10 | 4973_UP | |
| Drug | genistein | CYP1B1 FLT1 IQGAP2 GAPDH ENPP2 TOM1L1 MED14 PLCD4 BCAR1 PTEN RYK CLDN1 RYR2 PIK3R4 CLCA2 IL22 PLCG1 MMP1 LRBA | 2.75e-06 | 1117 | 114 | 19 | CID005280961 |
| Drug | 0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A | 6.85e-06 | 197 | 114 | 8 | 7069_UP | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; PC3; HT_HG-U133A | 6.85e-06 | 197 | 114 | 8 | 5796_DN | |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; PC3; HT_HG-U133A | 7.11e-06 | 198 | 114 | 8 | 6294_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.90e-05 | 175 | 114 | 7 | 6736_DN | |
| Drug | PCA 4248 | 3.37e-05 | 13 | 114 | 3 | CID000004698 | |
| Drug | aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A | 5.23e-05 | 192 | 114 | 7 | 6164_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 5.23e-05 | 192 | 114 | 7 | 2123_UP | |
| Drug | phthalazine | 5.32e-05 | 15 | 114 | 3 | CID000009207 | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 5.77e-05 | 195 | 114 | 7 | 3504_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A | 5.95e-05 | 196 | 114 | 7 | 4591_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; PC3; HT_HG-U133A | 5.95e-05 | 196 | 114 | 7 | 7129_UP | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 5.95e-05 | 196 | 114 | 7 | 5404_DN | |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 6.15e-05 | 197 | 114 | 7 | 3933_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 6.15e-05 | 197 | 114 | 7 | 3723_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 6.35e-05 | 198 | 114 | 7 | 4804_UP | |
| Drug | Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; PC3; HT_HG-U133A | 6.55e-05 | 199 | 114 | 7 | 5842_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 6.55e-05 | 199 | 114 | 7 | 6240_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 6.55e-05 | 199 | 114 | 7 | 2802_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A | 6.55e-05 | 199 | 114 | 7 | 5787_DN | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 6.55e-05 | 199 | 114 | 7 | 959_DN | |
| Disease | Malignant neoplasm of breast | CYP1B1 FLT1 CD109 MED14 ARFGEF2 BCAR1 PTEN CLDN1 PIK3R4 PTPN14 PBRM1 CLCA2 DHX32 MMP1 LRBA DOP1A | 2.39e-06 | 1074 | 110 | 16 | C0006142 |
| Disease | obstructive lung disease (is_implicated_in) | 1.38e-05 | 2 | 110 | 2 | DOID:2320 (is_implicated_in) | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 2.42e-05 | 45 | 110 | 4 | DOID:8947 (biomarker_via_orthology) | |
| Disease | cerebral cavernous malformation (is_marker_for) | 4.12e-05 | 3 | 110 | 2 | DOID:0060669 (is_marker_for) | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 4.12e-05 | 3 | 110 | 2 | C1842563 | |
| Disease | JOUBERT SYNDROME 17 | 1.37e-04 | 5 | 110 | 2 | C3553264 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.78e-04 | 139 | 110 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | brain disease (implicated_via_orthology) | 2.05e-04 | 6 | 110 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 2.77e-04 | 34 | 110 | 3 | DOID:5082 (biomarker_via_orthology) | |
| Disease | nicotine withdrawal symptom count | 3.02e-04 | 35 | 110 | 3 | EFO_0009263 | |
| Disease | Hepatocellular Adenoma | 4.87e-04 | 9 | 110 | 2 | C0206669 | |
| Disease | Spastic Paraplegia | 4.87e-04 | 9 | 110 | 2 | C0037772 | |
| Disease | Colorectal Neoplasms | 6.14e-04 | 277 | 110 | 6 | C0009404 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 7.27e-04 | 108 | 110 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | Ductal Carcinoma | 7.41e-04 | 11 | 110 | 2 | C1176475 | |
| Disease | cysteine-glutathione disulfide measurement | 7.41e-04 | 11 | 110 | 2 | EFO_0021001 | |
| Disease | Long QT Syndrome | 7.41e-04 | 11 | 110 | 2 | C0023976 | |
| Disease | Polydactyly | 9.81e-04 | 117 | 110 | 4 | C0152427 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.22e-03 | 14 | 110 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Saldino-Noonan Syndrome | 1.22e-03 | 14 | 110 | 2 | C0036069 | |
| Disease | Neoplasm Metastasis | 1.34e-03 | 217 | 110 | 5 | C0027627 | |
| Disease | infant head circumference | 1.40e-03 | 15 | 110 | 2 | EFO_0004577 | |
| Disease | Atherosclerosis | 1.41e-03 | 59 | 110 | 3 | C0004153 | |
| Disease | Atherogenesis | 1.41e-03 | 59 | 110 | 3 | C1563937 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.53e-03 | 132 | 110 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | proliferative diabetic retinopathy (is_marker_for) | 1.60e-03 | 16 | 110 | 2 | DOID:13207 (is_marker_for) | |
| Disease | myocardial infarction (implicated_via_orthology) | 1.94e-03 | 66 | 110 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | Hemangiosarcoma | 2.03e-03 | 18 | 110 | 2 | C0018923 | |
| Disease | basophil count, eosinophil count | 2.13e-03 | 241 | 110 | 5 | EFO_0004842, EFO_0005090 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 2.26e-03 | 19 | 110 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | emphysema pattern measurement | 2.26e-03 | 19 | 110 | 2 | EFO_0005850 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 2.26e-03 | 19 | 110 | 2 | DOID:4928 (is_marker_for) | |
| Disease | melanoma | 2.41e-03 | 248 | 110 | 5 | C0025202 | |
| Disease | sphingomyelin 16:0 measurement | 2.50e-03 | 20 | 110 | 2 | EFO_0010391 | |
| Disease | asthma, endometriosis | 2.70e-03 | 74 | 110 | 3 | EFO_0001065, MONDO_0004979 | |
| Disease | Joubert syndrome 1 | 2.76e-03 | 21 | 110 | 2 | C4551568 | |
| Disease | bone density, lean body mass | 2.76e-03 | 21 | 110 | 2 | EFO_0003923, EFO_0004995 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 2.76e-03 | 21 | 110 | 2 | OBA_2045104 | |
| Disease | LEOPARD Syndrome | 3.03e-03 | 22 | 110 | 2 | C0175704 | |
| Disease | Lung Neoplasms | 3.20e-03 | 265 | 110 | 5 | C0024121 | |
| Disease | Malignant neoplasm of lung | 3.25e-03 | 266 | 110 | 5 | C0242379 | |
| Disease | primary open angle glaucoma (is_implicated_in) | 3.31e-03 | 23 | 110 | 2 | DOID:1070 (is_implicated_in) | |
| Disease | Disease Exacerbation | 3.44e-03 | 165 | 110 | 4 | C0235874 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.60e-03 | 24 | 110 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.60e-03 | 24 | 110 | 2 | C3805278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YMGNEISYPLKPFLV | 236 | Q15078 | |
| DMFGYFEPLYQVIPD | 111 | Q8NC06 | |
| LQLPDYYTIIKNPMD | 61 | Q58F21 | |
| QYGQEVYDTPPMAVK | 261 | P56945 | |
| NVDYILPIMTQPYDF | 396 | Q8N157 | |
| YPYDMARTPTQEQLL | 771 | Q8IUX7 | |
| MEFPSLDPNNNYIYV | 3986 | Q6V0I7 | |
| QMPYPCYVDDIFLRV | 621 | O95477 | |
| MEDLVYNPEQVPRYY | 421 | A8K2U0 | |
| YPYLCEIMQFDLIPE | 1736 | Q9Y6D5 | |
| MLQFFYAYIQRIPVP | 1901 | Q5JWR5 | |
| PELFMQLVPQYYFSN | 686 | Q7L7V1 | |
| VLMQTVDPYTPDYQD | 61 | P51164 | |
| NMVLFAPNIYVLDYL | 976 | P01023 | |
| CVNLFVMPYNYPVLL | 376 | Q9UL03 | |
| RLLYDMFVNFPDQPV | 61 | Q9NVR2 | |
| FEYQEPMPTAVLEKY | 166 | Q68EN5 | |
| QPLENYLDMEYFGTI | 66 | P0DJD9 | |
| IYEPPRYMSVNQAAQ | 181 | Q9H2P9 | |
| DNAPVFVNLPYYAVV | 2076 | Q14517 | |
| LNQYLPNFYPLDMSE | 4486 | Q14517 | |
| QPDYYEVVSQPIDLM | 81 | Q86U86 | |
| QSYPMVLQYRPRIDF | 241 | Q86SE9 | |
| IQGNLQLDYPIFYVM | 231 | Q6P499 | |
| DQGDLMTPQFTPYYV | 176 | Q8IW41 | |
| SLLDLPPVNEYDMYI | 506 | Q8WVS4 | |
| SLVPYTMTPEQFVDY | 466 | Q8WYN3 | |
| YMPYPGRTNQEVLDF | 721 | P29376 | |
| AIMRTQVDPYLPYEY | 611 | Q3V5L5 | |
| PLYAVMYPVFNELER | 21 | Q9BUL8 | |
| IEMLLITTNPYDYPF | 301 | Q9UKX2 | |
| YAQYVKNTMEPLNIP | 411 | O76074 | |
| MFIPPSLIQLFDEYE | 766 | Q8IYU2 | |
| YQPIAGLYEPATMEQ | 106 | Q9HD67 | |
| LAMVDYPYASNFLQP | 286 | P42785 | |
| IPEFYYLPEMFVNFN | 2361 | P50851 | |
| MPYEYLRPSVVENSV | 646 | P16050 | |
| YNTTLPQFMPYEDGI | 1391 | O60449 | |
| PQFMPYEDGIYSVIQ | 1396 | O60449 | |
| PYNVMLYSDAPVSEL | 511 | O60337 | |
| LVFNIQPAPGMVYDY | 1406 | Q6IE36 | |
| QPLENYLDMEYFGTI | 66 | P0DJD8 | |
| PQYYIVVEMLEVPNK | 546 | O60244 | |
| LPFLIYQVMTDEPFQ | 171 | P25929 | |
| YPFNIEYQILASTML | 271 | Q7RTM1 | |
| YNPPRVQLSDEMFVF | 116 | Q8NA61 | |
| MINFAPNIYILDYLT | 926 | Q6YHK3 | |
| MYRQHQASILEYLPP | 636 | O60308 | |
| VELPVDVLYPYFMVQ | 206 | A1L0T0 | |
| PVPVIVNNFGMYYSL | 431 | P48547 | |
| DAQYPVVAVDSYMPV | 921 | Q4AC94 | |
| YAVTPIPDYVDVLQM | 1421 | Q8IZD9 | |
| QEFYDPMTPVNARYE | 146 | O95832 | |
| VYKFVSYPEILNMDP | 81 | P28324 | |
| YLVYLPSQMFEPQKL | 2231 | A8TX70 | |
| PTFLQMCEPYFLYLE | 126 | A6NJJ6 | |
| FPQYQPVVMLEKGYT | 1031 | Q9UHN6 | |
| MQYPVFPFILADYVS | 3161 | Q99698 | |
| VIQVPPEMRYTDYFV | 111 | Q96EH3 | |
| PNLPYVLAFLYEAMR | 376 | Q16678 | |
| IGQEPPEMNLYYENF | 21 | Q12951 | |
| FYYMKQPLTTDPVDV | 66 | Q9ULU4 | |
| LIPLLPQDFYYVAMD | 51 | Q9H4I8 | |
| TPYVDIDPFEMAAYL | 541 | P34925 | |
| DEPQLLYAIENKYMP | 1681 | Q92736 | |
| EEVTRPNYPGIMYLQ | 546 | Q13822 | |
| EVILIVPFYDCYEPM | 151 | Q6YP21 | |
| TYIYPNIIAMGFPAE | 26 | P60484 | |
| QPLENYLDMEYFGTI | 66 | P0DJD7 | |
| PYGADDFLPVLMYVL | 781 | Q8TB24 | |
| LAMSLDYDPLYVFNP | 646 | Q4G0U5 | |
| LIPLLPQDFYYVAMD | 51 | Q9NQF3 | |
| KDPPQLDYTQMLLYF | 1621 | Q9C093 | |
| PDYIAPEVFMQTGYN | 286 | Q15208 | |
| KPQYSMAVEFPLVLY | 311 | Q9BZE2 | |
| TMYLPSPEERNYEFL | 346 | Q969S9 | |
| LYPFKNDEVLPVMYI | 261 | Q8TAD8 | |
| GPQPLYDFTSQYVME | 671 | Q96KN7 | |
| LQPPNYYEVMEFDPL | 436 | O75674 | |
| SRTLEPYILPFMFYN | 1601 | A6NHR9 | |
| LDSDYPPLQQFFVVM | 36 | Q8WXA3 | |
| LPPFYSQDVSQMYEN | 231 | Q9HBY8 | |
| LPIYQDMTQPLNHYF | 286 | Q9BRC7 | |
| FYMRTNPFYPEVELN | 301 | P03956 | |
| FVPDYYKVIVNPMDL | 1536 | P21675 | |
| AQLPAVYPFAAAMYQ | 331 | Q13576 | |
| VAINDPFIDLNYMVY | 31 | P04406 | |
| AYNQPEDLVYSQPEM | 476 | Q15678 | |
| QLMPYLVLDILQDYP | 321 | Q8N695 | |
| PYTPFLTELMYQNLK | 771 | P41252 | |
| EEVLFPQSDRFQPYM | 101 | Q9GZX6 | |
| YPDYIQIAMPTESRN | 56 | Q8NHU3 | |
| DFIEEYVTAYPNRPM | 331 | Q15047 | |
| PVMIYANVKQGFYPI | 621 | Q9UQC9 | |
| FPEIFYTFLQPYMAQ | 316 | Q99570 | |
| IKPYIAEYDSPQNVM | 156 | Q9BU70 | |
| EYAIQQTPYEQPMKS | 246 | Q9P243 | |
| IPAPYEYMQQQVYDE | 866 | Q8IVF5 | |
| QLLEDYSEPQPSMFY | 556 | Q13905 | |
| NYLIRYMPFAPAIQT | 891 | P41226 | |
| PPLNVNEEYIIMGYE | 246 | Q92765 | |
| PGEPMEKYQVLYQLN | 21 | Q8NE28 | |
| QIIGENSPPDYSEYM | 241 | P25490 | |
| FPSNYVEEMVNPVAL | 841 | P19174 | |
| QAYPEYLITYQIMRP | 1146 | Q9H2K2 | |
| YLPEAMPASFQAIYT | 421 | Q92797 | |
| QLDVYPVPNYLSYMD | 886 | O60346 | |
| RLMEPYYFVEVQAPA | 826 | Q15029 | |
| MYLVIFPEGTRYNPE | 166 | Q9NUQ2 | |
| ADTLGYNIEPIMLYQ | 461 | A3KMH1 | |
| APEYSTPEIYQIMLD | 1121 | P17948 | |
| MLSEEPYIHANYQPV | 436 | Q92547 | |
| MPQDYIQYTVPLDEG | 216 | O14544 | |
| IQYTVPLDEGMYPLE | 221 | O14544 | |
| ESPEMLYVVHPYVQF | 226 | Q562E7 | |
| PVTYMLPADYNLFVE | 111 | O95922 | |
| FSPVVPYDMYILNAS | 61 | Q6SJ96 | |
| YEDIQYMQVPVADSP | 61 | Q8NEJ0 |